John P. Schmid

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Ajim Tamboli, Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for John P. Schmid

Form 4 holding Director

ANAPTYSBIO, INC

Security class
Restricted Stock Unit
Shares / value
4,000
Estimated value
$92,259
Report date
06 Jan 2026
Price
$15.30
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Xeris Biopharma Holdings, Inc.

Security class
Common Stock
Shares / value
25,200
Estimated value
$56,634
Report date
12 Aug 2024
Price
$2.25
Ownership
By: The Schmid Family Trust dated August 15, 2017
Form 4 holding Director

First Tracks Biotherapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
42,000
Estimated value
Report date
12 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

First Tracks Biotherapeutics, Inc.

Security class
Restricted Stock Unit
Shares / value
15,000
Estimated value
Report date
12 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ANAPTYSBIO, INC

Security class
Stock Option (right to buy)
Shares / value
5,500
Estimated value
Report date
20 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Poseida Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
08 Jan 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

XERIS PHARMACEUTICALS INC

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
05 Oct 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by John P. Schmid

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .